{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:20:27Z","timestamp":1795044027724,"version":"4.10.2"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-026-01284-1","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:21:24Z","timestamp":1789752084000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Area Under the Curve-Guided Therapeutic Drug Monitoring of Mycophenolic Acid in Lung Transplant Recipients: Volumetric Absorptive Microsampling and Population Pharmacokinetic-Based Limited Sampling Strategies"],"prefix":"10.1208","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-6807-6908","authenticated-orcid":false,"given":"Liang","family":"Juan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7119-5034","authenticated-orcid":false,"given":"Manjunath P.","family":"Pai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1220-2260","authenticated-orcid":false,"given":"Chao-Wen","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5722-0360","authenticated-orcid":false,"given":"Ching-Hua","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0376-1206","authenticated-orcid":false,"given":"Hsao-Hsun","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9940-0850","authenticated-orcid":false,"given":"Shu-Wen","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7963-029X","authenticated-orcid":false,"given":"Yu-Ju","family":"Tseng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"},{"role":"corresponding-author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,9,18]]},"reference":[{"key":"1284_CR1","unstructured":"Genentech USA, Inc. CellCept oral capsules, oral suspension, intravenous injection; mycophenolate mofetil oral capsules, oral tablets, oral suspension, intravenous injection: product information. South San Francisco (CA): Genentech USA, Inc.; 2000."},{"key":"1284_CR2","doi-asserted-by":"publisher","unstructured":"Allison AC, Eugui EM. The design and development of an immunosuppressive drug, mycophenolate mofetil. Springer Semin Immunopathol. 1993;14:353\u201380. https:\/\/doi.org\/10.1007\/BF00192309.","DOI":"10.1007\/BF00192309"},{"issue":"11","key":"1284_CR3","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1177\/0091270011422814","volume":"52","author":"H Kim","year":"2012","unstructured":"Kim H, Long\u2010Boyle J, Rydholm N, Orchard PJ, Tolar J, Smith AR, et al. Population pharmacokinetics of unbound mycophenolic acid in pediatric and young adult patients undergoing allogeneic hematopoietic cell transplantation. J Clin Pharmacol. 2012;52(11):1665\u201375.","journal-title":"J Clin Pharmacol"},{"key":"1284_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2020.105370","volume":"150","author":"JE Res\u00e9ndiz-Galv\u00e1n","year":"2020","unstructured":"Res\u00e9ndiz-Galv\u00e1n JE, Romano-Aguilar M, Medell\u00edn-Garibay SE, del Carmen Mil\u00e1n-Segovia R, del Carmen Ni\u00f1o-Moreno P, Jung-Cook H, et al. Population pharmacokinetics of mycophenolic acid in adult kidney transplant patients under prednisone and tacrolimus regimen. Eur J Pharm Sci. 2020;150:105370.","journal-title":"Eur J Pharm Sci"},{"issue":"1","key":"1284_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/bmt.2017.213","volume":"53","author":"K Yoshimura","year":"2018","unstructured":"Yoshimura K, Yano I, Yamamoto T, Kawanishi M, Isomoto Y, Yonezawa A, et al. Population pharmacokinetics and pharmacodynamics of mycophenolic acid using the prospective data in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 2018;53(1):44\u201351.","journal-title":"Bone Marrow Transplant"},{"issue":"4","key":"1284_CR6","doi-asserted-by":"publisher","first-page":"S141","DOI":"10.1016\/j.healun.2011.01.422","volume":"30","author":"B de Winter","year":"2011","unstructured":"de Winter B, Monchaud C, Pr\u00e9maud A, Pison C, Kessler R, Reynaud-Gaubert M, et al. 413 Pharmacokinetics of Mycophenolate Mofetil (MMF) in lung transplantation: comparison with renal transplantation. J Heart Lung Transplant. 2011;30(4):S141.","journal-title":"J Heart Lung Transplant"},{"issue":"6","key":"1284_CR7","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00228-015-1854-7","volume":"71","author":"X-X Wang","year":"2015","unstructured":"Wang X-X, Feng MR, Nguyen H, Smith DE, Cibrik DM, Park JM. Population pharmacokinetics of mycophenolic acid in lung transplant recipients with and without cystic fibrosis. Eur J Clin Pharmacol. 2015;71(6):673\u20139.","journal-title":"Eur J Clin Pharmacol"},{"key":"1284_CR8","doi-asserted-by":"publisher","first-page":"107290","DOI":"10.1016\/j.ejps.2025.107290","volume":"214","author":"K Juliette","year":"2025","unstructured":"Juliette K, S\u00e9verine F, Aur\u00e9lie B-T, Alexandra D, Tiphaine L, C\u00e9line V, et al. Population pharmacokinetics of mycophenolic acid and Bayesian estimator in lung transplant adults recipients in the early post-transplant period. Eur J Pharm Sci. 2025;214:107290.","journal-title":"Eur J Pharm Sci"},{"key":"1284_CR9","doi-asserted-by":"publisher","first-page":"859351","DOI":"10.3389\/fphar.2022.859351","volume":"13","author":"P Wang","year":"2022","unstructured":"Wang P, Xie H, Zhang Q, Tian X, Feng Y, Qin Z, et al. Population pharmacokinetics of mycophenolic acid in renal transplant patients: a comparison of the early and stable posttransplant stages. Front Pharmacol. 2022;13:859351.","journal-title":"Front Pharmacol"},{"issue":"1","key":"1284_CR10","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2165\/11594050-000000000-00000","volume":"51","author":"BC de Winter","year":"2012","unstructured":"de Winter BC, Monchaud C, Pr\u00e9maud A, Pison C, Kessler R, Reynaud-Gaubert M, et al. Bayesian estimation of mycophenolate mofetil in lung transplantation, using a population pharmacokinetic model developed in kidney and lung transplant recipients. Clin Pharmacokinet. 2012;51(1):29\u201339.","journal-title":"Clin Pharmacokinet"},{"issue":"8","key":"1284_CR11","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1080\/00498254.2016.1214885","volume":"47","author":"X-X Wang","year":"2017","unstructured":"Wang X-X, Liu W, Zheng T, Park JM, Smith DE, Feng MR. Population pharmacokinetics of mycophenolic acid and its glucuronide metabolite in lung transplant recipients with and without cystic fibrosis. Xenobiotica. 2017;47(8):697\u2013704.","journal-title":"Xenobiotica"},{"issue":"4","key":"1284_CR12","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1097\/00007691-200108000-00001","volume":"23","author":"LM Shaw","year":"2001","unstructured":"Shaw LM, Holt DW, Oellerich M, Meiser B, van Gelder T. Current issues in therapeutic drug monitoring of mycophenolic acid: report of a roundtable discussion. Ther Drug Monit. 2001;23(4):305\u201315.","journal-title":"Ther Drug Monit"},{"issue":"2","key":"1284_CR13","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/01.ftd.0000199358.80013.bd","volume":"28","author":"T Van Gelder","year":"2006","unstructured":"Van Gelder T, Le Meur Y, Shaw LM, Oellerich M, DeNofrio D, Holt C, et al. Therapeutic drug monitoring of mycophenolate mofetil in transplantation. Ther Drug Monit. 2006;28(2):145\u201354.","journal-title":"Ther Drug Monit"},{"issue":"8","key":"1284_CR14","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1097\/01.tp.0000232697.38021.9a","volume":"82","author":"W Arns","year":"2006","unstructured":"Arns W, Cibrik DM, Walker RG, Mourad G, Budde K, Mueller EA, et al. Therapeutic drug monitoring of mycophenolic acid in solid organ transplant patients treated with mycophenolate mofetil: review of the literature. Transplantation. 2006;82(8):1004\u201312.","journal-title":"Transplantation"},{"issue":"2","key":"1284_CR15","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1097\/FTD.0000000000000871","volume":"43","author":"S Bergan","year":"2021","unstructured":"Bergan S, Brunet M, Hesselink DA, Johnson-Davis KL, Kunicki PK, Lemaitre F, et al. Personalized therapy for mycophenolate: consensus report by the international association of therapeutic drug monitoring and clinical toxicology. Ther Drug Monit. 2021;43(2):150\u2013200.","journal-title":"Ther Drug Monit"},{"issue":"2","key":"1284_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/00007890-199907270-00018","volume":"68","author":"T Van Gelder","year":"1999","unstructured":"Van Gelder T, Hilbrands L, Vanrenterghem Y, Weimar W, De Fijter J, Squifflet J, et al. A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation1. Transplantation. 1999;68(2):261\u20136.","journal-title":"Transplantation."},{"issue":"1","key":"1284_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.healun.2024.09.007","volume":"44","author":"LK Tague","year":"2025","unstructured":"Tague LK, Anthony H, Salama NN, Hachem RR, Gage BF, Gelman AE. An integrated sampling strategy for therapeutic mycophenolic acid monitoring in lung transplant recipients. J Heart Lung Transplant. 2025;44(1):46\u201356.","journal-title":"J Heart Lung Transplant"},{"key":"1284_CR18","doi-asserted-by":"publisher","first-page":"16123","DOI":"10.3389\/jpps.2026.16123","volume":"29","author":"L Juan","year":"2026","unstructured":"Juan L, Cheng C-N, Chang W-C, Chiu H-H, Lu C-W, Hsu H-H, et al. Evaluation of hematocrit-adjusted conversion strategies for mycophenolic acid and tacrolimus monitoring using volumetric absorptive microsampling in lung and renal transplant recipients. J Pharm Pharm Sci. 2026;29:16123.","journal-title":"J Pharm Pharm Sci"},{"issue":"1","key":"1284_CR19","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/bmc.1367","volume":"24","author":"W Li","year":"2010","unstructured":"Li W, Tse FL. Dried blood spot sampling in combination with LC\u2010MS\/MS for quantitative analysis of small molecules. Biomed Chromatogr. 2010;24(1):49\u201365.","journal-title":"Biomed Chromatogr"},{"issue":"5","key":"1284_CR20","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/jac\/dks011","volume":"67","author":"W Kromdijk","year":"2012","unstructured":"Kromdijk W, Mulder JW, Rosing H, Smit PM, Beijnen JH, Huitema AD. Use of dried blood spots for the determination of plasma concentrations of nevirapine and efavirenz. J Antimicrob Chemother. 2012;67(5):1211\u20136.","journal-title":"J Antimicrob Chemother"},{"issue":"2","key":"1284_CR21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1365-2710.2008.00896.x","volume":"33","author":"D Teshima","year":"2008","unstructured":"Teshima D, Maiguma T, Kaji H, Otsubo K, Kitagawa N, Okabe Y, et al. Estimation of the area under the curve for mycophenolic acid in adult renal transplant patients with concomitant tacrolimus using a limited sampling strategy. J Clin Pharm Ther. 2008;33(2):159\u201363.","journal-title":"J Clin Pharm Ther"},{"issue":"5","key":"1284_CR22","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1365-2710.2009.01034.x","volume":"34","author":"M Tutor\u2010Crespo","year":"2009","unstructured":"Tutor\u2010Crespo M, Hermida J, Romero R, Tutor J. Two sampling time profiles for the abbreviated estimation of mycophenolic acid area under the curve in adult renal transplant recipients treated with mycophenolate mofetil and concomitant tacrolimus. J Clin Pharm Ther. 2009;34(5):531\u20137.","journal-title":"J Clin Pharm Ther"},{"issue":"9","key":"1284_CR23","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/clinchem\/48.9.1497","volume":"48","author":"T Pawinski","year":"2002","unstructured":"Pawinski T, Hale M, Korecka M, Fitzsimmons WE, Shaw LM. Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus. Clin Chem. 2002;48(9):1497\u2013504.","journal-title":"Clin Chem"},{"issue":"8","key":"1284_CR24","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.70275","volume":"39","author":"K Deng","year":"2025","unstructured":"Deng K, Liu J, Liu Y, Huang J, Xi Q, Yang G. Population pharmacokinetics and limited sampling strategy of mycophenolate mofetil for patients in early period after kidney transplantation. Clin Transplant. 2025;39(8):e70275.","journal-title":"Clin Transplant"},{"issue":"1","key":"1284_CR25","doi-asserted-by":"publisher","DOI":"10.1111\/bcpt.70056","volume":"137","author":"K Agergaard","year":"2025","unstructured":"Agergaard K, Thiesson HC, Carstens J, Staatz CE, J\u00e4rvinen E, Nielsen F, et al. Limited sampling strategies to predict mycophenolic acid and tacrolimus area under the concentration-time curve in steroid-free kidney transplant patients. Basic Clin Pharmacol Toxicol. 2025;137(1):e70056.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"5","key":"1284_CR26","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1111\/bcp.16374","volume":"91","author":"Y Fromage","year":"2025","unstructured":"Fromage Y, Sayadi H, Koloskoff K, Marquet P, Labriffe M, Monchaud C, et al. Killing several birds with one stone: a multi-indication population pharmacokinetic model and Bayesian estimator for enteric-coated mycophenolate sodium. Br J Clin Pharmacol. 2025;91(5):1396\u2013408.","journal-title":"Br J Clin Pharmacol"},{"issue":"6","key":"1284_CR27","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1097\/FTD.0000000000001336","volume":"47","author":"ME Mohamed","year":"2025","unstructured":"Mohamed ME, Saqr A, Onyeaghala G, Remmel RP, Staley C, Dorr CR, et al. Simultaneous prediction of area under the curves of mycophenolic acid and its metabolites and enterohepatic recirculation in kidney transplant recipients. Ther Drug Monitor. 2025;47(6):799\u2013808.","journal-title":"Ther Drug Monitor"},{"issue":"2","key":"1284_CR28","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/FTD.0b013e3182a8eea9","volume":"36","author":"L Stuckey","year":"2014","unstructured":"Stuckey L, Ojo TC, Park JM, Annesley T, Bartos C, Cibrik DM. Mycophenolic acid pharmacokinetics in lung transplant recipients with cystic fibrosis. Ther Drug Monit. 2014;36(2):148\u201351.","journal-title":"Ther Drug Monit"},{"issue":"2","key":"1284_CR29","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.bpa.2017.07.004","volume":"31","author":"C Potestio","year":"2017","unstructured":"Potestio C, Jordan D, Kachulis B. Acute postoperative management after lung transplantation. Best Pract Res Clin Anaesthesiol. 2017;31(2):273\u201384.","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"7","key":"1284_CR30","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1111\/j.1600-6143.2009.02682.x","volume":"9","author":"S Kofler","year":"2009","unstructured":"Kofler S, Shvets N, Bigdeli A, K\u00f6nig M, Kaczmarek P, Deutsch MA, et al. Proton pump inhibitors reduce mycophenolate exposure in heart transplant recipients\u2014a prospective case-controlled study. Am J Transplant. 2009;9(7):1650\u20136.","journal-title":"Am J Transplant"},{"issue":"12","key":"1284_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/cts.70097","volume":"17","author":"Y Suzuki","year":"2024","unstructured":"Suzuki Y, Matsunaga N, Aoyama T, Ogami C, Hasegawa C, Iida S, et al. Population pharmacokinetic analysis identifies an absorption process model for mycophenolic acid in patients with renal transplant. Clin Transl Sci. 2024;17(12):e70097.","journal-title":"Clin Transl Sci"},{"issue":"1","key":"1284_CR32","doi-asserted-by":"publisher","first-page":"13","DOI":"10.2165\/00003088-200746010-00002","volume":"46","author":"CE Staatz","year":"2007","unstructured":"Staatz CE, Tett SE. Clinical pharmacokinetics and pharmacodynamics of mycophenolate in solid organ transplant recipients. Clin Pharmacokinet. 2007;46(1):13\u201358.","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"1284_CR33","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.2165\/00003088-200544100-00006","volume":"44","author":"RM van Hest","year":"2005","unstructured":"van Hest RM, van Gelder T, Vulto AG, Mathot RA. Population pharmacokinetics of mycophenolic acid in renal transplant recipients. Clin Pharmacokinet. 2005;44(10):1083\u201396.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"1284_CR34","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1007\/s11096-019-00837-z","volume":"41","author":"A Spasi\u0107","year":"2019","unstructured":"Spasi\u0107 A, Cati\u0107-\u0110or\u0111evi\u0107 A, Veli\u010dkovi\u0107-Radovanovi\u0107 R, Stefanovi\u0107 N, D\u017eodi\u0107 P, Cvetkovi\u0107 T. Adverse effects of mycophenolic acid in renal transplant recipients: gender differences. Int J Clin Pharm. 2019;41(3):776\u201384.","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"1284_CR35","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/s40262-017-0593-6","volume":"57","author":"TK Kiang","year":"2018","unstructured":"Kiang TK, Ensom MH. Population pharmacokinetics of mycophenolic acid: an update. Clin Pharmacokinet. 2018;57(5):547\u201358.","journal-title":"Clin Pharmacokinet"},{"issue":"12","key":"1284_CR36","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1080\/17425255.2021.2027906","volume":"17","author":"Y Rong","year":"2021","unstructured":"Rong Y, Patel V, Kiang TK. Recent lessons learned from population pharmacokinetic studies of mycophenolic acid: physiological, genomic, and drug interactions leading to the prediction of drug effects. Expert Opin Drug Metab Toxicol. 2021;17(12):1369\u2013406.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"1","key":"1284_CR37","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/bcpt.13743","volume":"131","author":"Y Liu","year":"2022","unstructured":"Liu Y, Zhang H, Li J, Liu L, Wu C, Fu Q, et al. Pharmacokinetics of free and total mycophenolic acid in paediatric and adult renal transplant recipients: exploratory analysis of the effects of clinical factors and gene variants. Basic Clin Pharmacol Toxicol. 2022;131(1):60\u201373.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"4","key":"1284_CR38","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s40268-020-00319-y","volume":"20","author":"F Riglet","year":"2020","unstructured":"Riglet F, Bertrand J, Barrail-Tran A, Verstuyft C, Michelon H, Benech H, et al. Population pharmacokinetic model of plasma and cellular mycophenolic acid in kidney transplant patients from the CIMTRE study. Drugs in R&D. 2020;20(4):331\u201342.","journal-title":"Drugs in R&D"},{"key":"1284_CR39","doi-asserted-by":"publisher","first-page":"483","DOI":"10.12659\/AOT.894954","volume":"20","author":"J Zegarska","year":"2015","unstructured":"Zegarska J, Hryniewiecka E, \u017bochowska D, Tszyrsznic W, Jazwiec R, Borowiec A, et al. Mycophenolic acid metabolites acyl-glucuronide and glucoside affect the occurrence of infectious complications and bone marrow dysfunction in liver transplant recipients. Ann Transplant. 2015;20:483\u201392.","journal-title":"Ann Transplant"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01284-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-026-01284-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01284-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:14:32Z","timestamp":1795043672000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-026-01284-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["1284"],"URL":"https:\/\/doi.org\/10.1208\/s12248-026-01284-1","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,18]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"152"}}